Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Rexhaj E, Bär S, Soria R, Ueki Y, Häner JD, Otsuka T, Kavaliauskaite R, Siontis GC, Stortecky S, Shibutani H, Spirk D, Engstrøm T, Lang I, Morf L, Ambühl M, Windecker S, Losdat S, Koskinas KC, Räber L; PACMAN-AMI Investigators.
Rexhaj E, et al. Among authors: ueki y.
Atherosclerosis. 2024 Mar 6;392:117504. doi: 10.1016/j.atherosclerosis.2024.117504. Online ahead of print.
Atherosclerosis. 2024.
PMID: 38513436
Free article.